135 related articles for article (PubMed ID: 34784305)
1. Primary tumor location in lung cancer: the evaluation and administration.
Xie X; Li X; Tang W; Xie P; Tan X
Chin Med J (Engl); 2021 Nov; 135(2):127-136. PubMed ID: 34784305
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of the primary tumor location based on the hilar structures in non-small cell lung cancer with mediastinal lymph node metastasis.
Ito M; Yamashita Y; Miyata Y; Ohara M; Tsutani Y; Ikeda T; Misumi K; Harada H; Omori K
Lung Cancer; 2012 Apr; 76(1):93-7. PubMed ID: 22285532
[TBL] [Abstract][Full Text] [Related]
3. Involvement of lymphatic metastatic spread in non-small cell lung cancer accordingly to the primary cancer location.
Kotoulas CS; Foroulis CN; Kostikas K; Konstantinou M; Kalkandi P; Dimadi M; Bouros D; Lioulias A
Lung Cancer; 2004 May; 44(2):183-91. PubMed ID: 15084383
[TBL] [Abstract][Full Text] [Related]
4. Location of stage I-III non-small cell lung cancer and survival rate: Systematic review and meta-analysis.
Lee HW; Lee CH; Park YS
Thorac Cancer; 2018 Dec; 9(12):1614-1622. PubMed ID: 30259691
[TBL] [Abstract][Full Text] [Related]
5. Mediastinal nodal involvement in patients with clinical stage I non-small-cell lung cancer: possibility of rational lymph node dissection.
Haruki T; Aokage K; Miyoshi T; Hishida T; Ishii G; Yoshida J; Tsuboi M; Nakamura H; Nagai K
J Thorac Oncol; 2015 Jun; 10(6):930-6. PubMed ID: 26001143
[TBL] [Abstract][Full Text] [Related]
6. New perspective to evaluate N1 staging: The peripheral lymph node metastasis status of non-small cell lung cancer.
Zhang J; Liu L; Wang G; Huang C; Chen Y; Zhang Y; Guo C; Li S
Thorac Cancer; 2019 Dec; 10(12):2253-2258. PubMed ID: 31617316
[TBL] [Abstract][Full Text] [Related]
7. Including positive lymph node count in the AJCC N staging may be a better predictor of the prognosis of NSCLC patients, especially stage III patients: a large population-based study.
Fan Y; Du Y; Sun W; Wang H
Int J Clin Oncol; 2019 Nov; 24(11):1359-1366. PubMed ID: 31183778
[TBL] [Abstract][Full Text] [Related]
8. [Clinical analysis of skip N2 metastases in stage IIIA non-small cell lung cancer].
Liu K; Chen HL; You QS; Huang JF; Wang H
Ai Zheng; 2009 Jul; 28(7):725-9. PubMed ID: 19624899
[TBL] [Abstract][Full Text] [Related]
9. Assessment of non-lobe-specific lymph node metastasis in clinical stage IA non-small cell lung cancer.
Zhang Z; Miao J; Chen Q; Fu Y; Li H; Hu B
Thorac Cancer; 2019 Jul; 10(7):1597-1604. PubMed ID: 31206253
[TBL] [Abstract][Full Text] [Related]
10. [Correlation between Lymph Node Ratio and Clinicopathological Features and Prognosis of IIIa-N2 Non-small Cell Lung Cancer].
Zhang S; Wang L; Lu F; Pei Y; Yang Y
Zhongguo Fei Ai Za Zhi; 2019 Nov; 22(11):702-708. PubMed ID: 31771739
[TBL] [Abstract][Full Text] [Related]
11. Do tumours located in the left lower lobe have worse outcomes in lymph node-positive non-small cell lung cancer than tumours in other lobes?
Kudo Y; Saji H; Shimada Y; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N
Eur J Cardiothorac Surg; 2012 Sep; 42(3):414-9. PubMed ID: 22398463
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of clinical N0 metastatic non-small cell lung cancer.
Tamura T; Kurishima K; Watanabe H; Shiozawa T; Nakazawa K; Ishikawa H; Satoh H; Hizawa N
Lung Cancer; 2015 Jul; 89(1):71-5. PubMed ID: 25913230
[TBL] [Abstract][Full Text] [Related]
13. Time to refine N2 staging? cN2α and cN2β based on local regional involvement provide a more accurate prognosis in surgically treated IIIA non-small-cell lung cancer than N2 alone or the number of node stations involved.
Matsunaga T; Suzuki K; Takamochi K; Oh S
Eur J Cardiothorac Surg; 2014 Jul; 46(1):86-91. PubMed ID: 24321998
[TBL] [Abstract][Full Text] [Related]
14. Results of surgical intervention for p-stage IIIA (N2) non-small cell lung cancer: acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobe.
Inoue M; Sawabata N; Takeda S; Ohta M; Ohno Y; Maeda H
J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1100-6. PubMed ID: 15052208
[TBL] [Abstract][Full Text] [Related]
15. Retrospective analysis of nodal spread patterns according to tumor location in pathological N2 non-small cell lung cancer.
Shimada Y; Saji H; Kakihana M; Honda H; Usuda J; Kajiwara N; Ohira T; Ikeda N
World J Surg; 2012 Dec; 36(12):2865-71. PubMed ID: 22948194
[TBL] [Abstract][Full Text] [Related]
16. Resectable left lower lobe non-small cell lung cancer with lymph node metastasis is related to unfavorable outcomes.
Ye WF; Xie X; Yang H; Luo KJ; Liu QW; Zheng YZ; Wang JY
Chin J Cancer; 2016 Jan; 35():7. PubMed ID: 26738896
[TBL] [Abstract][Full Text] [Related]
17. Poor survival of non-small-cell lung cancer patients with main bronchus tumor: a large population-based study.
Li C; Liu J; Lin J; Li Z; Shang X; Wang H
Future Oncol; 2019 Aug; 15(24):2819-2827. PubMed ID: 31393163
[No Abstract] [Full Text] [Related]
18. Lymph node metastasis outside of a tumor-bearing lobe in primary lung cancer and the status of interlobar fissures: The necessity for removing lymph nodes from an adjacent lobe.
Li H; Wang R; Zhang D; Zhang Y; Li W; Zhang B; Liu Q; Du J
Medicine (Baltimore); 2019 Mar; 98(12):e14800. PubMed ID: 30896623
[TBL] [Abstract][Full Text] [Related]
19. Superior and basal segment lung cancers in the lower lobe have different lymph node metastatic pathways and prognosis.
Watanabe S; Suzuki K; Asamura H
Ann Thorac Surg; 2008 Mar; 85(3):1026-31. PubMed ID: 18291191
[TBL] [Abstract][Full Text] [Related]
20. Subcarinal Lymph Nodes Should be Dissected in All Lobectomies for Non-Small Cell Lung Cancer-Regardless of Primary Tumor Location.
Eckardt J; Jakobsen E; Licht PB
Ann Thorac Surg; 2017 Apr; 103(4):1121-1125. PubMed ID: 28109572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
